A scrappy pioneer industry like cannabis attracts CEOs with diverse backgrounds. Before becoming a weed titan, Bruce Linton, the CEO of Canopy Growth (WEED.T) was an IT executive. Adam…
Research
The U.S. Drug Enforcement Agency (D.E.A.) says it will be “moving forward to facilitate and expand scientific and medical research for marijuana,” allowing for additional federally-permitted cannabis cultivators. Despite…
Earlier this week, a subsidiary of Lexaria Bioscience (LXX.C) received a R&D license from Health Canada, prompting the question, ‘we have those?’ “You were as surprised as we were,” said…
The Green Organic Dutchman Holdings (TGOD.T) has finally sent its inaugural shipment of its certified organic cannabis to the Ontario Cannabis Store. This first shipment represents a significant benchmark…
Chemesis International (CSI.C) has signed letters of intent (LOIs) with 34 private liquor stores in British Columbia to distribute their hemp-based chew products. Not everybody likes to smoke dried…
Andy DeFrancesco is the devil. Just ask anyone. The worst guy in the weed business, the archangel of bad asset deals, the shell master of Florida. He’s got investigative…
Several years ago, when Equity.Guru boss Chris Parry was writing at Stockhouse, he was called out to a new client – a company called Abattis Bioceutical (ATT.C). Abattis execs…
The Canadian Securities Exchange is not known for rigorous compliance protocols. However, it does have some standards, and cannabis health product company Abattis Bioceuticals (ATT.C) was unable to meet…
Endocanna Health, a subsidiary of Heritage Cannabis (CANN.C), has agreed to manufacture and license its patent-pending Endocannabinoid DNA Test Kits to Empower Clinics (CBDT.C). Imagine a product tuned in…
We all know someone who’s been touched by cancer. It’s been called the worst scourge of civilized mankind. It sweeps through a family, disrupting our perfectly ordered lives, throwing…